QQ客服 官方微博 反馈留言

	Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
	Li, Xue; Lian, Zhen; Wang, Shuai; Xing, Ligang; Yu, Jinming
刊名	CANCER LETTERS
	2018
卷号	418页码:1-9
关键词	Non-small cell lung cancer Epidermal growth factor receptor Programmed cell death receptor/ligand 1 tyrosine kinase inhibitors
DOI	10.1016/j.canlet.2018.01.005
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4574391
专题	山东大学
作者单位	1.Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Radiat Oncol, Tianjin 300060, Peoples R China. 2.[Li, Xue 3.Wan
推荐引用方式 GB/T 7714	Li, Xue,Lian, Zhen,Wang, Shuai,et al. Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC[J]. CANCER LETTERS,2018,418:1-9.
APA	Li, Xue,Lian, Zhen,Wang, Shuai,Xing, Ligang,&Yu, Jinming.(2018).Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC.CANCER LETTERS,418,1-9.
MLA	Li, Xue,et al."Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC".CANCER LETTERS 418(2018):1-9.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。